Document Detail


Regression of left ventricular hypertrophy with isradipine in previously untreated hypertensive patients.
MedLine Citation:
PMID:  8466737     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The regression of left ventricular hypertrophy (LVH) is considered a desirable goal of antihypertensive treatment. Isradipine was used as first-line antihypertensive treatment in 15 patients who had mild-to-moderate hypertension and LVH, and who were studied before and after 6 months of treatment. Left ventricular mass and function were assessed by Doppler echocardiography. Systolic and diastolic blood pressure were reduced from 161 +/- 14 mm Hg and 103 +/- 3 mm Hg to 136 +/- 8 mm Hg and 87 +/- 6 mm Hg, respectively (P < .001). The interventricular septal thickness was reduced by 11.9% (P < .001), posterior wall thickness by 11.1% (P < .001), left ventricular end-diastolic diameter by 2%, and left ventricular mass index by 17% (P < .02). In conclusion, 6 months of antihypertensive treatment of mild-to-moderate hypertension with isradipine achieves a significant regression (17%) of LVH.
Authors:
A J Manolis; G Kolovou; S Handanis; G Athanasopoulos; S Antonopoulos; D V Cokkinos
Related Documents :
6413087 - Beneficial effects of dopamine combined with intravenous nitroglycerin on hemodynamics ...
6239837 - The effect of pulmonic and aortic constriction on regional left ventricular thickening ...
131007 - Cardiac performance in rats with renal hypertension.
2427827 - Electropharmacologic synergism with mexiletine and quinidine.
8739877 - Absolute cardiovascular risk: the basis for deciding to treat.
22548407 - Update on new aspects of the renin-angiotensin system in liver disease: clinical implic...
Publication Detail:
Type:  Clinical Trial; Journal Article    
Journal Detail:
Title:  American journal of hypertension     Volume:  6     ISSN:  0895-7061     ISO Abbreviation:  Am. J. Hypertens.     Publication Date:  1993 Mar 
Date Detail:
Created Date:  1993-05-10     Completed Date:  1993-05-10     Revised Date:  2009-02-24    
Medline Journal Info:
Nlm Unique ID:  8803676     Medline TA:  Am J Hypertens     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  86S-88S     Citation Subset:  IM    
Affiliation:
Cardiology Department, Tzanio Hospital, Piraeus, Greece.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Echocardiography, Doppler
Female
Heart Ventricles / ultrasonography
Humans
Hypertension / complications,  drug therapy*
Hypertrophy, Left Ventricular / drug therapy*,  etiology,  ultrasonography
Isradipine / therapeutic use*
Male
Middle Aged
Treatment Outcome
Chemical
Reg. No./Substance:
75695-93-1/Isradipine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Regression of left ventricular hypertrophy with isradipine antihypertensive therapy.
Next Document:  Reversal of left ventricular hypertrophy with isradipine induces diminution of cardiac arrhythmias.